Laboratorios SALVAT SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Laboratorios SALVAT SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2803
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laboratorios SALVAT SA (SALVAT) is a pharmaceutical company with focus on the development and commercialization of innovative medicines. The company manufactures drugs in various segments such as personal healthcare, digestive / metabolism, urological conditions, ophthalmological diseases, ENT, dermatology and malaria. It also offers antiseptics, nutraceuticals and probiotics. SALVAT’s R&D efforts extend to ENT and ophthalmology, dermatology and gastroenterology. It established SALVAT Biotech to pursue advancements in molecular diagnosis, regenerative medicine and new forms of drug delivery. The company has operations with a commercial office in the US, and markets its products through a network of distributors across Europe, America, Asia and Africa, and the Middle East. SALVAT is headquartered in Barcelona, Spain.

Laboratorios SALVAT SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios SALVAT SA, Medical Devices Deals, 2012 to YTD 2018 9
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
iCo Therapeutics Enters into Licensing Agreement with Laboratorios SALVAT 11
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 12
Laboratorios SALVAT Enters into Licensing Agreement with Pediapharm 13
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 14
Equity Offering 15
Loop Therapeutics Spin Off from Laboratorios SALVAT 15
Laboratorios SALVAT SA – Key Competitors 16
Laboratorios SALVAT SA – Key Employees 17
Laboratorios SALVAT SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Product News 19
05/18/2017: Pediapharm Announces the Commercial Launch of Otixal in Canada 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Key Facts 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios SALVAT SA, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios SALVAT SA, Medical Devices Deals, 2012 to YTD 2018 9
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
iCo Therapeutics Enters into Licensing Agreement with Laboratorios SALVAT 11
Laboratorios SALVAT Enters into Licensing Agreement with Lee’s Pharma 12
Laboratorios SALVAT Enters into Licensing Agreement with Pediapharm 13
Laboratorios SALVAT Enters Into Licensing Agreement With FAES Farma 14
Loop Therapeutics Spin Off from Laboratorios SALVAT 15
Laboratorios SALVAT SA, Key Competitors 16
Laboratorios SALVAT SA, Key Employees 17
Laboratorios SALVAT SA, Subsidiaries 18

List of Figures
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laboratorios SALVAT SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laboratorios SALVAT SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Laboratorios SALVAT SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CIncinnati Children’s Hospital Medical Center:企業のM&A・事業提携・投資動向
    CIncinnati Children's Hospital Medical Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CIncinnati Children's Hospital Medical Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • Corline Biomedical AB (CLBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Corline Biomedical AB (Corline Biomedical), formerly Corline Systems AB is a manufacturer of heparin based solutions. The company offers heparin based solutions to improve kidney transplantation, and applications in the field of regenerative medicine. Its regentrative medicines include cytop …
  • First Quantum Minerals Ltd:戦略・SWOT・企業財務分析
    First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report Summary First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Fortitech Inc.:戦略・SWOT・企業財務分析
    Fortitech Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortitech Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Advisory Board Company:企業の戦略的SWOT分析
    The Advisory Board Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sunquest Information Systems Inc:企業の戦略的SWOT分析
    Sunquest Information Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Central National-Gottesman Inc.:企業の戦略・SWOT・財務情報
    Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report Summary Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Clinigen Group Plc (CLIN):企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • SOHO Global Health:企業の戦略的SWOT分析
    SOHO Global Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Daniel Thwaites Plc:企業の戦略・SWOT・財務情報
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Recreational Equipment Inc:企業の戦略・SWOT・財務情報
    Recreational Equipment Inc - Strategy, SWOT and Corporate Finance Report Summary Recreational Equipment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bafna Pharmaceuticals Ltd (BAFNAPHARM)-製薬・医療分野:企業M&A・提携分析
    Summary Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company which manufactures and markets pharmaceutical products. The company’s operations include domestic marketing, international marketing, international export and business development. Its products comprise raricap, ra …
  • United Natural Foods Inc:企業の戦略・SWOT・財務情報
    United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report Summary United Natural Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Centre de Regulacio Genomica-製薬・医療分野:企業M&A・提携分析
    Summary Centre de Regulacio Genomica (CRG) is a biomedical institute that provides research services. The institute provides research programs such as bioinformatics and genomics, cell and developmental biology, gene regulation, stem cells and cancer and systems biology, among others. It offers faci …
  • Laredo Petroleum, Inc. (LPI)-石油・ガス分野:企業M&A・提携分析
    Summary Laredo Petroleum, Inc. (Laredo), formerly known as Laredo Petroleum Holdings, Inc., is an independent energy company that acquires assets, and explores for, develops and produces oil and natural gas properties. It also gathers oil and liquids-rich natural gas from its properties. The company …
  • PT Supreme Cable Manufacturing & Commerce Tbk (SCCO):企業の財務・戦略的SWOT分析
    PT Supreme Cable Manufacturing & Commerce Tbk (SCCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Life Time Inc:企業の戦略的SWOT分析
    Life Time Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Stater Bros. Markets:企業の戦略・SWOT・財務情報
    Stater Bros. Markets - Strategy, SWOT and Corporate Finance Report Summary Stater Bros. Markets - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Latecoere S.A.:企業の戦略・SWOT・財務情報
    Latecoere S.A. - Strategy, SWOT and Corporate Finance Report Summary Latecoere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Albireo Pharma Inc (ALBO):医療機器:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆